Study of serum pentraxin 3 level in patients with diabetic nephropathy

The Egyptian Journal of Internal Medicine

Table 1 Comparison between the studied groups as regards demographic data

Variables		Group I (N = 22)	Group II (N = 22)	Group III-A (N = 22)	Group III-B (N = 22)	ANOVA test or χ² test		Post hoc test
Variables		Group I (N = 22)	Group II (N = 22)	Group III-A (N = 22)	Group III-B (N = 22)	F/χ²*	P value	Post hoc test
Age, years	Mean	52.64	54.68	57.36	65.95	20.466	< 0.001 HS	P1 0.27	P2 0.01	P3 < 0.001
Age, years	± SD	6.33	6.68	6.71	4.24	20.466	< 0.001 HS	P4 0.15	P5 < 0.001	P6 < 0.001
Gender,n(%)	Male	11 (50%)	13 (59.1%)	14 (63.6%)	12 (54.5%)	0.926*	0.819	P1 0.93	P2 0.78	P3 0.61
Gender,n(%)	Female	11 (50%)	9 (40.9%)	8 (36.4%)	10 (45.5%)	0.926*	0.819	P4 0.76	P5 0.64	P6 0.88
BMI	Mean	24.17	25.35	26.69	27.42	16.727	< 0.001 HS	P1 0.02	P2 < 0.001	P3 < 0.001
BMI	± SD	1.44	1.32	1.92	1.84	16.727	< 0.001 HS	P4 0.01	P5 < 0.001	P6 0.15
Duration	Mean	–	8.09	11.09	16.77	132.421	< 0.001 HS	P1 –	P2 –	P3 –
Duration	± SD	–	1.38	1.15	2.54	132.421	< 0.001 HS	P4 < 0.001	P5 < 0.001	P6 < 0.001
Smoking,n(%)	No	15 (68.2%)	16 (72.7%)	12 (54.5%)	13 (59.1%)	1.964*	0.580	P1 0.86	P2 0.56	P3 0.77
Smoking,n(%)	Yes	7 (31.8%)	6 (27.3%)	10 (45.5%)	9 (40.9%)	1.964*	0.580	P4 0.39	P5 0.41	P6 0.47
SBP, mmHg	Mean	122.27	127.05	124.55	135.91	4.811	0.004 S	P1 0.22	P2 0.56	P3 < 0.001
SBP, mmHg	± SD	10.88	14.69	11.74	13.42	4.811	0.004 S	P4 0.52	P5 0.02	P6 < 0.001
DBP, mmHg	Mean	73.41	77.50	73.18	82.95	8.309	< 0.001 HS	P1 0.07	P2 0.92	P3 < 0.001
DBP, mmHg	± SD	6.25	9.35	5.24	8.26	8.309	< 0.001 HS	P4 0.06	P5 0.02	P6 < 0.001

N number, SD standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, F ANOVA test, χ² chi-square test (*), P1 group I vs group II, P2 group I vs group III-A, P3 group I vs group III-B, P4 group II vs group III-A, P5 group II vs group III-B, P6 group III-A vs group III-B, HS P value < 0.001 is considered highly significant, S P value < 0.05 is considered significant